V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240016347 | 240007724 | 1.65 | 84.4 | Palliative (P) | 2018-07-17 | 2018-09-19 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 240030765 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016348 | 240007736 | 0 | 51.3 | Palliative (P) | 2017-05-25 | 2017-05-25 | Bevacizumab | 1 | N | 240030813 | BEVACIZUMAB |
| 240016349 | 240007807 | 1.74 | 80.4 | Curative (C) | 2019-01-10 | 2019-01-21 | Trial Unspecified | 2 | N | 240031247 | TRIAL |
| 240016350 | 240012195 | 1.65 | 5.82 | Curative (C) | 2020-04-07 | 2020-04-08 | R Chlorambucil | 2 | N | 240031288 | CHLORAMBUCIL + RITUXIMAB |
| 240016351 | 240007924 | 1.6 | 83.4 | Curative (C) | 2017-09-24 | 2017-10-05 | ABVD | N | N | 240031919 | GDP |
| 240016352 | 240016118 | 1.69 | 46 | Curative (C) | 2014-04-06 | 2014-04-08 | IBRUTINIB | 02 | N | 240032483 | LENALIDOMIDE |
| 240016353 | 240008054 | 1.58 | null | Curative (C) | 2019-04-29 | 2019-05-09 | Hydroxycarbamide | N | null | 240032600 | CISPLATIN + TOPOTECAN |
| 240016354 | 240008187 | 1.65 | 80.7 | Curative (C) | 2018-06-05 | 2018-09-27 | LEAM | 1 | N | 240033543 | DA |
| 240016355 | 240008235 | 1.67 | null | Palliative (P) | 2019-06-01 | 2019-06-02 | DHAP | null | null | 240033833 | GEMCITABINE |
| 240016356 | 240008386 | null | 62.6 | Palliative (P) | 2014-12-05 | 2014-12-11 | DA 3+8 | N | Y | 240034689 | METHOTREXATE HIGH DOSE |
| 240016357 | 240012526 | 1.7 | 77.6 | Curative (C) | 2014-07-01 | 2014-07-01 | AML 19 TRIAL | 2 | N | 240035318 | CAPECITABINE + CARBOPLATIN |
| 240016358 | 240008682 | 1.71 | 58.5 | Palliative (P) | 2017-05-02 | 2017-06-01 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 240009661 | TOPOTECAN |
| 240016359 | 240008714 | 1.29 | 61.3 | Palliative (P) | 2018-12-16 | 2019-01-26 | DA-EPOCH-R | N | N | 240011523 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240016360 | 240008781 | 1.57 | 63 | Curative (C) | 2018-10-16 | 2018-11-11 | MABCUTE TRIAL | N | N | 240016111 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 240016361 | 240008844 | 1.65 | 41 | Curative (C) | 2019-10-18 | 2020-06-19 | Topotecan (oral) | 02 | N | 240020689 | UKALL60+ |
| 240016362 | 240008850 | 1.6 | 142 | Palliative (P) | 2016-07-20 | 2016-07-27 | MABCUTE TRIAL | 1 | null | 240020856 | R CODOX M |
| 240016363 | 240012769 | 1.57 | 62.3 | Disease modification (D) | 2018-09-05 | 2018-09-11 | CVP | N | N | 240023933 | TOPOTECAN |
| 240016364 | 240012827 | null | 70.8 | Palliative (P) | 2018-02-24 | 2018-11-09 | Carboplatin + Docetaxel | 02 | N | 240015030 | CARBOPLATIN + LIPOSOMAL DOX |
| 240016365 | 240006211 | 1.78 | 68.8 | Curative (C) | 2020-08-06 | 2021-06-26 | Rituximab | 2 | N | 240009601 | RITUXIMAB |
| 240016366 | 240006359 | null | 78.9 | Disease modification (D) | 2016-06-15 | 2016-06-19 | Rituximab | 2 | N | 240010555 | RITUXIMAB |
| 240016367 | 240006516 | 1.6 | 50 | Curative (C) | 2019-01-15 | 2019-01-15 | Rituximab | N | N | 240011479 | RITUXIMAB |
| 240016368 | 240007724 | 1.6 | 98.9 | null | 2018-08-05 | 2018-10-03 | Bevacizumab | null | null | 240030765 | BEVACIZUMAB |
| 240016369 | 240007737 | 1.53 | 43 | Curative (C) | 2017-06-03 | 2017-07-01 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 2 | N | 240030813 | NOT MATCHED |
| 240016370 | 240007807 | 1.58 | 130.8 | Disease modification (D) | 2019-02-12 | 2019-02-17 | DA 3 + 10 | 02 | N | 240031247 | BEAM |
| 240016371 | 240007924 | 1.84 | 82.4 | Curative (C) | 2018-07-25 | 2018-07-30 | Methotrexate High Dose (3g/m2) | N | N | 240031919 | BENDAMUSTINE |
| 240016372 | 240008027 | 1.74 | 61.7 | Palliative (P) | null | 2014-08-13 | Carboplatin + Etoposide iv&po | null | null | 240032483 | ABVD |
| 240016373 | 240008055 | 1.63 | 65.9 | Palliative (P) | 2019-04-08 | 2019-07-11 | Gemcitabine + Oxaliplatin | Y | N | 240032600 | CARBOPLATIN + RT |
| 240016374 | 240008235 | 1.72 | 75.3 | Curative (C) | 2019-08-23 | 2019-08-25 | CISPLATIN + FLUOROURACIL | 02 | N | 240033833 | ATG + BUSULFAN + FLUDARABINE |
| 240016375 | 240015428 | 1.63 | 68.7 | Palliative (P) | 2017-06-06 | 2017-06-07 | Carboplatin + Topotecan | N | null | 240009661 | GEMTUZUMAB OZOGAMICIN |
| 240016376 | 240008925 | 1.58 | 76.8 | Disease modification (D) | 2018-10-09 | 2018-10-09 | CYTARABINE + METHOTREXATE | N | N | 240023933 | VEDEX |
| 240016377 | 240012827 | 1.62 | 51 | Palliative (P) | 2017-05-31 | 2018-11-09 | AML 18 TRIAL | 2 | N | 240015030 | OFATUMUMAB |
| 240016378 | 240011366 | null | null | Curative (C) | 2020-10-23 | 2021-06-26 | Rituximab | 2 | N | 240009601 | RITUXIMAB |
| 240016379 | 240006360 | 1.6 | 0 | Curative (C) | 2015-11-02 | 2016-06-19 | Rituximab | N | N | 240010555 | RITUXIMAB |
| 240016380 | 240011523 | null | 84.4 | Disease modification (D) | 2019-02-02 | 2019-02-12 | Methotrexate intrathecal | 01 | N | 240011479 | METHOTREXATE INTRATHECAL |
| 240016381 | 240012158 | 1.7 | 64.7 | Palliative (P) | 2017-07-20 | 2017-11-25 | BEVACIZUMAB + CARBO + PACLITAXEL | 1 | N | 240030813 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240016382 | 240007925 | 0 | 69 | Curative (C) | 2018-08-15 | 2018-09-12 | NHL 2003 Gp B COPADM 1 & 2 | N | N | 240031919 | FLUDARABINE + MELPHALAN |
| 240016383 | 240012314 | 1.67 | 39.6 | Palliative (P) | 2018-08-16 | 2019-07-24 | BLEOMYCIN + CHLORAMBUCIL + LOMUSTINE + METHOTREXATE + RITUXIMAB + VINBLASTINE | Y | N | 240032600 | REMODL TRIAL |
| 240016384 | 240008925 | 1.68 | 81.5 | Disease modification (D) | 2018-09-27 | 2018-10-09 | RUXOLITINIB | N | N | 240023933 | CARBOPLATIN + VINORELBINE |
| 240016385 | 240012827 | 1.65 | 82.3 | Palliative (P) | 2018-05-25 | 2018-12-14 | DA-EPOCH-R | 02 | N | 240015030 | IPM |
| 240016386 | 240013899 | null | 93 | Disease modification (D) | 2019-02-12 | 2019-02-12 | UKALL14- Ph 1 Induction | Y | N | 240011479 | ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |
| 240016387 | 240013899 | 1.7 | 111 | Disease modification (D) | 2019-02-26 | 2019-02-26 | DHAP - R | 1 | N | 240011479 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 240016388 | 240015736 | 1.75 | 59.2 | Disease modification (D) | 2019-04-13 | 2019-04-14 | CAPECITABINE + OXALIPLATIN | 2 | N | 240011479 | CISPLATIN + GEMCITABINE |
| 250000001 | 250000001 | null | null | Disease modification (D) | null | 2016-11-20 | Hydroxycarbamide | N | N | 250000006 | HYDROXYCARBAMIDE |
| 250000002 | 250000002 | null | 0 | Palliative (P) | 2017-06-27 | 2017-06-27 | Hydroxycarbamide | 2 | N | 250000008 | HYDROXYCARBAMIDE |
| 250000003 | 250008308 | 0 | 0 | Disease modification (D) | 2017-04-20 | 2017-04-20 | Hydroxycarbamide | N | N | 250000012 | HYDROXYCARBAMIDE |
| 250000004 | 250000003 | null | null | Palliative (P) | 2014-08-29 | 2016-06-29 | Hydroxycarbamide | N | N | 250000019 | HYDROXYCARBAMIDE |
| 250000005 | 250000003 | 1.69 | null | Disease modification (D) | 2013-05-27 | 2013-08-13 | Hydroxycarbamide | 02 | N | 250000019 | HYDROXYCARBAMIDE |
| 250000006 | 250000004 | null | 0 | Disease modification (D) | 2016-07-10 | 2016-07-10 | Hydroxycarbamide | 02 | N | 250000022 | HYDROXYCARBAMIDE |
| 250000007 | 250000005 | 0 | 72.5 | Disease modification (D) | 2016-07-11 | 2016-07-11 | Hydroxycarbamide | N | N | 250000023 | HYDROXYCARBAMIDE |
| 250000008 | 250000006 | 0 | null | Disease modification (D) | 2014-01-15 | 2014-01-15 | Hydroxycarbamide | N | N | 250000026 | HYDROXYCARBAMIDE |